Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open‑label extension MG0004 study

The roles of interleukin (IL)-17A and IL-17F in hidradenitis suppurativa pathogenesis: evidence from human in vitro preclinical experiments and clinical samples

Long-term safety and effectiveness of fenfluramine in children and adults with Dravet syndrome

Subcutaneous zilucoplan: evaluation of reproductive toxicology

Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions

Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension

Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and its open-label extension

Evaluation of the effect of rozanolixizumab on pregnancy outcomes and pre- and postnatal development in cynomolgus monkeys

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Neonatal Fc Receptor Inhibitor Rozanolixizumab: An Ethnic Sensitivity Study in Healthy Japanese, Chinese, and White Participants

Impact of high RF levels on treatment outcomes of certolizumab pegol and adalimumab in RA: a post hoc analysis from the phase 4 EXXELERATE trial